Effect of Cholesterol Level on Platelet Aggregability in Normal Individuals

نویسندگان

  • Mohammad Faheem
  • Ibrahim Shah
  • Lubna Noor
  • Muhammad Adil
  • Hameedullah
  • Mohammad Hafizullah
چکیده

Objective: The aim of present study was to find the effect of cholesterol level on platelet aggregability in normal individuals. Methodology: This study was conducted in Cardiology department, Lady Reading Hospital, Peshawar in SeptemberOctober 2007. Normal individuals aged 18 years or above were randomly included. Patients who were suffering from any cardiovascular or other diseases were excluded. Those who were taking ante-platelets, anti coagulants and lipid lowering drugs were also excluded. Thus a total of 101 individuals were examined, after taking informed written consent. Fasting blood samples were taken from each patient. Total cholesterol was measured in hospital laboratory, while platelet aggregation was measured with chronolog whole-blood platelet aggregometer (WBA). Results: A total of 101 patients were examined. Their mean age was 51.24 ± 8.23 years. Male were 60(59.41%) and female were 41(40.59%). Mean platelet aggregability of these individuals was 7.87 ± 4.40 ohms. Mean cholesterol was 163.47 ± 20.75 mg/dl. When age was correlated with aggregability, both had a weak negative correlation. Pearson correlation coefficient was -.018 (p=0.855). When age was correlated with cholesterol, again both have a weak negative correlation. Pearson correlation coefficient was -.152 (p=0.129). When aggregability was correlated with cholesterol, both have a significant positive correlation. Pearson correlation coefficient was +0.269 (p=0.006) Conclusion: Platelet aggregability is increased in patients with high cholesterol. These patients may need higher doses of anti platelets and more aggressive treatment of lipids to avoid vascular events.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Association of platelet aggregation with lipid levels in the Japanese population: the Suita study.

AIM Platelets play a pivotal role in atherothrombotic diseases. Platelet aggregability induced by agonists has great interindividual variability; however, the factors influencing platelet aggregability variation have not been characterized in Asia. METHODS To examine the confounding factors influencing platelet counts and responsiveness to agonists, we measured the platelet counts and platele...

متن کامل

Epidemiological characteristics of platelet aggregability.

The epidemiological characteristics of platelet aggregability were established in 958 participants in the Northwick Park Heart Study. The main analyses were based on the dose of adenosine diphosphate at which primary aggregation occurred at half its maximum velocity. Aggregability increased with age in both sexes, was greater in whites than blacks (particularly among men), and tended to decreas...

متن کامل

Adiponectin added into the plasma of healthy probands does not affect platelet aggregability.

Six healthy non-obese probands without medical therapy and history of disease were tested. In all of them platelet aggregability with addition of human recombinant adiponectin in different concentrations (100; 75; 50 and 25 ng/l) were measured. It is concluded that increased level of adiponectin has no significant antiaggregation effect on platelets from individuals without hypoadiponectinemia.

متن کامل

Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase.

BACKGROUND Hypercholesterolemia enhances platelet aggregability. Statins have beneficial effects on cardiovascular events. The purpose of this study is to investigate whether statins inhibit platelet aggregation and, if so, the mechanisms. METHODS AND RESULTS Twelve patients with hypercholesterolemia were prospectively randomized in a crossover design to receive either fluvastatin (20 mg/d) o...

متن کامل

Frequency of Dual Anti Platelet Resistance in Patients with Coronary Artery Disease

Objectives: To find the frequency of dual antiplatelet resistance in patients with coronary artery disease. Material and Methods: This study was conducted in the Department of Cardiology, Lady Reading Hospital, Peshawar, from January 2007 to February 2008. A total of 105 normal individuals not taking any anti platelet drug and 108 patients taking dual anti platelet drugs for coronary artery dis...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2013